Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Postpartum Vaginal Estrogen for Breastfeeding Patients

NCT: NCT05457972 · RECRUITING

NCT IDNCT05457972
StatusRECRUITING
Start Date2025-02-22
Completion2026-12-31
SponsorUniversity Hospitals Cleveland Medical Center (OTHER)
First posted
Last updated

Brief Summary

Sexual dysfunction is very common in the postpartum period and is more common in people who breastfeed or pump. This research study was designed to help determine whether postpartum patients who use vaginal estrogen cream while breastfeeding have improved sexual function compared to postpartum patients who do not.

Frequently Asked Questions

What is Postpartum Vaginal Estrogen for Breastfeeding Patients?

Postpartum Vaginal Estrogen for Breastfeeding Patients is a clinical trial registered under NCT05457972. Current status: RECRUITING.

What is the status of NCT05457972?

The current status of NCT05457972 (Postpartum Vaginal Estrogen for Breastfeeding Patients) is: RECRUITING.

When did Postpartum Vaginal Estrogen for Breastfeeding Patients start?

Postpartum Vaginal Estrogen for Breastfeeding Patients started on 2025-02-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑